Forschungsprojekte
Ergebnisse pro Seite:
10
2023 - 2030
Early treatment intensification in patients with high risk Mantle Cell Lymphoma using CAR-T-cell treatment after an abbreviated induction therapy with Rituximab and Ibrutinib and 6 months Ibrutinib maintenance (Arm A) as compared to standard of care induction and maintenance (Arm B)- Prof. Dr. med. Georg Heß
2021 - 2027
A Phase 1/2a First-in-human Study to Evaluate the Safety, Tolerability and Efficacy of IMA401, a bispecific T cell engaging receptor molecule (TCER®) in patients with recurrent and/or refractory solid tumors.- Marius Fried,
- Dr. med. Alexander Desuki
2021 - 2027
Pre-Screening for A Phase Ia/Ib first-in-human clinical trial to evaluate the safety, tolerability and Initial anti-tumor activity of IMA401, a bispecific T cell engaging receptor molecule (TCER®), in patients with recurrent and/or refractory solid tumors- Marius Fried,
- Dr. med. Alexander Desuki
2015 - 2017
Platelet function in pooled and apheresis platelet concentrates- Prof. Dr. Walter E. Hitzler,
- Katharina Blath
2015 - 2017
Prevalence of Hepatitis E among Blood Donors- Dr. Stefan Runkel,
- Prof. Dr. Walter E. Hitzler
2013 - 2014
Production of autologous serum eye drops- Dr. Dana Marandiuc,
- Dr. Ronland Conradi,
- Dr. Stefan Runkel
2013 - 2014
Evaluation of the automated system DAYmate M for donor and patient blood grouping- Dr. Dana Marandiuc,
- Prof. Dr. Walter E. Hitzler,
- Susanne Seifert-Hitzler
2013
Validation of Spectra Optia apheresis-system for collection of peripheral blood stem cells- Dr. Dana Marandiuc,
- Prof. Dr. Walter E. Hitzler
2012 - 2014
Stability of clotting factors in Fresh Frozen Plasma (FFP) produced and stored und different conditions- Dr. Stefan Runkel,
- Prof. Dr. Walter Hitzler